Quinn Opportunity Partners LLC Pro Phase Labs, Inc. Transaction History
Quinn Opportunity Partners LLC
- $1.34 Billion
- Q1 2025
A detailed history of Quinn Opportunity Partners LLC transactions in Pro Phase Labs, Inc. stock. As of the latest transaction made, Quinn Opportunity Partners LLC holds 318,127 shares of PRPH stock, worth $139,975. This represents 0.01% of its overall portfolio holdings.
Number of Shares
318,127Holding current value
$139,975% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding PRPH
# of Institutions
37Shares Held
4.95MCall Options Held
0Put Options Held
0-
Wexford Capital LP Greenwich, CT1.53MShares$671,2680.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$179,6370.0% of portfolio
-
Four World Capital Management LLC New York, NY377KShares$165,6930.1% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny300KShares$131,9160.0% of portfolio
-
Citizens Financial Group Inc270KShares$118,9760.0% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $7.05M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...